Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Kangpu Biopharmaceuticals Successfully Completed Phase I Study of Novel CRL4-CRBN Modulator KPG-818 in the U.S. 2019-10-11 13:00
WuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast New Chemical Space of Tangible Molecules 2019-10-11 08:02
I-Mab Biopharma Receives IND Approval in China for Proprietary CD73 Antibody TJD5 2019-10-04 13:40
Medicago's New Drug Submission accepted for scientific review by Health Canada: An important step for Medicago towards commercialization of its innovative influenza vaccine 2019-10-03 06:30
Mayne Pharma Signs 20-Year Exclusive License and Supply Agreement for Novel Oral Contraceptive in the US 2019-10-02 12:01
Shanghai Pharma Global Standard Stock Incentive Scheme to Push Innovation Refiled for Approval 2019-10-01 04:00
Ascletis Announces Departure of Chief Financial Officer 2019-09-30 16:30
Adlai Nortye Presents Encouraging Phase 1b Study Data of AN0025 (an Oral EP4 Antagonist) for Locally Advanced Rectal Cancer at ESMO 2019 2019-09-30 13:41
The 10th China (Taizhou) International Medical Expo successfully ended 2019-09-30 13:27
Bridge Biotherapeutics Presents Positive Results from Phase 1 Clinical Study of BBT-877 for Idiopathic Pulmonary Fibrosis (IPF) Treatments at the ERS International Congress 2019 2019-09-30 06:00
Kinoxis Therapeutics Awarded NIH HEAL Initiative Grant to Advance KNX100 for the Treatment of Opioid Withdrawal 2019-09-30 05:00
CYZone announced "The 2019 Top 50 Healthcare Innovation Enterprises" in China 2019-09-26 21:36
Preclincal Results of Baoyuan's Next-Generation ROS1/NTRK Inhibitor AB-106 Published in Nature Communications 2019-09-25 18:35
China Biologic Forms Special Committee to Review "Going Private" Proposal 2019-09-24 20:00
I-Mab Biopharma Announces Clinical Collaboration to Evaluate TJC4 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Multiple Cancer Types 2019-09-23 19:00
CARsgen Announces Investigational CAR-T Therapy CT053 Granted PRIME Eligibility by the European Medicines Agency 2019-09-23 18:00
More Than 9 in 10 Surgeons Encounter a Needlestick Injury, New Global Survey Finds 2019-09-20 07:00
Chipscreen Biosciences's Oringinal New Drug Bilessglu® (for Type 2 Diabetes): Commercialization Application Accepted 2019-09-19 23:02
WuXi Diagnostics to open its first research facility in the U.S. 2019-09-19 20:00
China Biologic Announces Receipt of Preliminary Non-Binding "Going Private" Proposal 2019-09-19 04:01
1 220 221 222 223 224 436